---
figid: PMC6549747__PGPM-12-59-g0002
figlink: /pmc/articles/PMC6549747/figure/F0002/
number: Figure 2
caption: 'The interaction between tumor microenvironment components, including stromal
  cells, and tumor cells leads to enhanced cell growth, proliferation, angiogenesis
  and invasion. Breast cancer epithelial cells increase tumor cell proliferation and
  invasion while inhibiting apoptosis through either of these following pathways:
  (1) classical pathway in which estrogen binds to its receptor, ER, or (2) non-classical
  pathway that involves post-translational modifications of ER by activation kinases,
  and transcription factors. Anti-cancer agents including tamoxifen (TAM), whose metabolites,
  4-OH TAM and endoxifen, have higher affinity for ER when compared with TAM, exert
  their effects by modulating signaling pathways that regulate tumor cells.Note: Data
  adapted from Russell and Barone et al.'
pmcid: PMC6549747
papertitle: 'Personalized medicine in breast cancer: pharmacogenomics approaches.'
reftext: Shabnam Jeibouei, et al. Pharmgenomics Pers Med. 2019;12:59-73.
pmc_ranked_result_index: '23932'
pathway_score: 0.9427289
filename: PGPM-12-59-g0002.jpg
figtitle: Interaction between tumor microenvironment components, including stromal
  cells, and tumor cells leads to enhanced cell growth, proliferation, angiogenesis
  and invasion
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6549747__PGPM-12-59-g0002.html
  '@type': Dataset
  description: 'The interaction between tumor microenvironment components, including
    stromal cells, and tumor cells leads to enhanced cell growth, proliferation, angiogenesis
    and invasion. Breast cancer epithelial cells increase tumor cell proliferation
    and invasion while inhibiting apoptosis through either of these following pathways:
    (1) classical pathway in which estrogen binds to its receptor, ER, or (2) non-classical
    pathway that involves post-translational modifications of ER by activation kinases,
    and transcription factors. Anti-cancer agents including tamoxifen (TAM), whose
    metabolites, 4-OH TAM and endoxifen, have higher affinity for ER when compared
    with TAM, exert their effects by modulating signaling pathways that regulate tumor
    cells.Note: Data adapted from Russell and Barone et al.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FUS
  - PRKACA
  - CYP3A4
  - CYP3A5
  - PRKAR1B
  - PRKACB
  - PRKACG
  - PIK3R3
  - CDK4
  - PRKAR2A
  - PRKAR2B
  - PRKAR1A
  - MAPK12
  - MYC
  - NFKB1
  - NFKB2
  - JUN
  - MAPK11
  - MAPK14
  - MAPK1
  - JUND
  - FOSL1
  - CDK6
  - CCND1
  - CYP2D6
  - PIK3CG
  - AKT3
  - AKT1
  - AKT2
  - REL
  - RELA
  - RELB
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - CYP19A1
  - MAPK9
  - MAPK10
  - MAPK13
  - FOSB
  - FOSL2
  - FOS
  - MAPK3
  - MAPK8
  - PIK3CA
  - JUNB
  - PIK3CD
  - PIK3CB
  - Androgen
  - Anastrozol
  - TAM
  - 4-OH TAM
  - Endoxifen
  - cancer
genes:
- word: FUS
  symbol: FUS
  source: hgnc_symbol
  hgnc_symbol: FUS
  entrez: '2521'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: CYP3A4/A5
  symbol: CYP3A4
  source: hgnc_symbol
  hgnc_symbol: CYP3A4
  entrez: '1576'
- word: CYP3A4/A5
  symbol: CYP3A5
  source: hgnc_symbol
  hgnc_symbol: CYP3A5
  entrez: '1577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: JUN
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CYP2D6
  symbol: CYP2D6
  source: hgnc_symbol
  hgnc_symbol: CYP2D6
  entrez: '1565'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals:
- word: Androgen
  source: MESH
  identifier: D000728
- word: Anastrozol
  source: ''
  identifier: ''
- word: TAM
  source: MESH
  identifier: C419191
- word: 4-OH TAM
  source: MESH
  identifier: C419191
- word: Endoxifen
  source: MESH
  identifier: C055492
diseases:
- word: cancer
  source: MESH
  identifier: D009369
---
